| Date Checked | 2025-12-21 23:36:15 |
|---|---|
| Graham Number | (PB)25.13 vs (PE)24.05 |
| Over / Under Value Percentage | -0.36% vs 3.96% |
| Dividend Yield | 6.65% |
| Dividend Date | 2025-12-01 |
| Symbol | PFE |
| AssetType | Common Stock |
| Name | Pfizer Inc |
| Description | Pfizer Inc. is a preeminent global pharmaceutical and biotechnology firm based in New York City, with a storied legacy of innovation since its founding in 1849. The company is renowned for its diverse therapeutic portfolio, which spans immunology, oncology, and cardiology, and is supported by a robust pipeline of groundbreaking treatments. Notably, Pfizer's rapid development of the COVID-19 vaccine underscored its agility in research and commitment to addressing urgent public health needs. Through strategic collaborations and ongoing investment in cutting-edge research, Pfizer is poised to sustain its leadership position in the healthcare sector while continuing to improve health outcomes worldwide. |
| CIK | 78003 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address | 66 HUDSON BOULEVARD EAST, NEW YORK, NY, UNITED STATES, 10001-2192 |
| OfficialSite | https://www.pfizer.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 146122686000 |
| EBITDA | 24459000000 |
| PERatio | 14.94 |
| PEGRatio | 14.06 |
| BookValue | 16.32 |
| DividendPerShare | 1.7 |
| EPS | 1.72 |
| RevenuePerShareTTM | 11.06 |
| ProfitMargin | 0.157 |
| OperatingMarginTTM | 0.353 |
| ReturnOnAssetsTTM | 0.0519 |
| ReturnOnEquityTTM | 0.106 |
| RevenueTTM | 62784999000 |
| GrossProfitTTM | 46968001000 |
| DilutedEPSTTM | 1.72 |
| QuarterlyEarningsGrowthYOY | -0.213 |
| QuarterlyRevenueGrowthYOY | -0.059 |
| AnalystTargetPrice | 29.04 |
| AnalystRatingStrongBuy | 3 |
| AnalystRatingBuy | 7 |
| AnalystRatingHold | 15 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 14.94 |
| ForwardPE | 8.44 |
| PriceToSalesRatioTTM | 2.327 |
| PriceToBookRatio | 1.567 |
| EVToRevenue | 3.046 |
| EVToEBITDA | 10.31 |
| Beta | 0.425 |
| 52WeekHigh | 27.21 |
| 52WeekLow | 19.83 |
| 50DayMovingAverage | 25.04 |
| 200DayMovingAverage | 24.56 |
| SharesOutstanding | 5685708000 |
| SharesFloat | 5675928000 |
| PercentInsiders | 0.076 |
| PercentInstitutions | 67.413 |
| ExDividendDate | 2025-11-07 |
| naga | 1 |
| etoro | 1 |
| dateChecked | 2025-12-21 23:36:15 |
| fresh | 1 |